Arrow raises 11.1 million in venture capital

The anti-infectives company Arrow Therapeutics (London, U.K.) raised 11.1 million ($16.8 million). GIMV invested 2.75 million; Alta Partners, TVM, and 3i each invested 2.25 million; Northern Venture M...